In this randomized trial , strut coverage and neointimal proliferation of a therapy of bare metal stents ( BMSs ) postdilated with the paclitaxel drug-eluting balloon ( DEB ) was compared with everolimus drug-eluting stents ( DESs ) at 6-month follow-up using optical coherence tomography .